What are Lastacaft and loteprednol, and how do they differ?
Lastacaft (alcaftadine) is an antihistamine eye drop used to treat the itching caused by allergic conjunctivitis. [1]
Loteprednol is a corticosteroid eye drop used to reduce inflammation in the eye. The specific brand/formulation varies by product, but the key difference is that loteprednol is for inflammation, not itching alone. [2]
When would a doctor choose Lastacaft instead of loteprednol?
Lastacaft is typically used when the main problem is allergic itching from conditions like seasonal or perennial allergic conjunctivitis. [1]
Because it works as an antihistamine, it targets the allergic symptoms without adding steroid exposure. [1]
When would a doctor choose loteprednol instead of Lastacaft?
Loteprednol is generally chosen when there is ocular inflammation that needs a steroid to calm it down, which can occur in non-infectious inflammatory eye conditions or when inflammation is a prominent feature. [2]
If a patient has allergy symptoms plus significant inflammation, a clinician might add a steroid rather than rely on antihistamine alone.
Can they be used together?
They can be used in combination in some treatment plans because they address different mechanisms: Lastacaft targets allergic itching while loteprednol targets inflammatory pathways. [1][2]
How to space doses and how long to use each should be determined by the prescriber, since steroid use has important monitoring considerations.
Are there different risks patients worry about?
Because Lastacaft is not a steroid, it avoids steroid-specific concerns tied to corticosteroids in the eye. [1]
Loteprednol, as a corticosteroid, carries risks that can include elevated eye pressure and other steroid-associated effects depending on the product and duration of use, so clinicians often limit duration and monitor if use is extended. [2]
Which one tends to work faster for allergy symptoms?
For classic allergic conjunctivitis symptoms like itching, Lastacaft’s antihistamine action is usually the direct symptom match. [1]
Loteprednol can reduce inflammation-related redness and discomfort, but it is not the primary targeted treatment for “itch only” allergy symptoms. [2]
What to consider before switching between them
If symptoms are mainly itching from allergies, Lastacaft is often the more targeted option. [1]
If symptoms include clear inflammatory findings where a clinician wants to suppress inflammation, loteprednol may be appropriate. [2]
If you’re considering switching, the main driver should be what symptom pattern and diagnosis is being treated, not just how you feel day to day.
What about cost and patent/biosimilar issues?
For brand vs generics and access issues, DrugPatentWatch.com can help track patent status and related market exclusivity signals for specific products. [3]
---
Sources
- Lastacaft (alcaftadine) prescribing information / FDA label on DrugPatentWatch.com
- Loteprednol prescribing information (DrugPatentWatch.com listing for loteprednol)
- DrugPatentWatch.com